Andrea Denker is Professor of "Accelerator Physics for Medicine"
Prof. Dr. Andrea Denker is the head of the department "Proton Therapy" at HZB. © HZB/ M. Setzpfandt
The Beuth Hochschule für Technik Berlin and the Helmholtz-Zentrum Berlin (HZB) have appointed Prof. Dr. Andrea Denker to the joint professorship "Accelerator Physics for Medicine" as of October 1, 2018. Since 2006, Andrea Denker is head of the department "Proton Therapy" at the HZB, which operates the accelerator for eye tumor therapy. The therapy, offered in cooperation with the Charité - Universitätsmedizin Berlin and the HZB, is unique in Germany.
As part of her professorship, Andrea Denker is taking on lectures in the "Physical Technology - Medical Physics" course at Beuth University. In the current winter semester she offers the lecture "Atomic and Nuclear Physics" for Bachelor students.
Even before her appointment, Andrea Denker was a lecturer at the university. "I enjoy this job very much and the contact with the students is very enriching for me and my team at HZB," says Denker. The appointment now creates an even closer connection to the university. "We are already looking forward to many interesting theses that will be written at the proton accelerator at the HZB.
Andrea Denker studied and received her doctorate in physics at the University of Stuttgart. Then she worked at the CSNSM (Centre de Sciences Nucléaires et de Sciences de la Matière) in Orsay, France. In 1995 Andrea Denker started as a scientist at the ion accelerator ISL. Among other things, she calculated and developed the beam parameters for eye tumor therapy, which was launched 20 years ago.
- A duo for BESSY III light sourceSince 1 March 2026, Renske van der Veen and Andreas Jankowiak have formed the leadership team of BESSY III. Together, they will drive forward HZB’s central project: the planning and realisation of BESSY III light source in Berlin-Adlershof. Here, they talk about their motivation, the next steps, and why BESSY III is a a cross-generational project.
- Protein crystallography at BESSY II: faster, better and more and more automaticMany diseases are linked to malfunctions of proteins in the organism. The three-dimensional architecture of these molecules is often highly complex, but it can provide valuable insights into biological processes and the development of drugs. X-ray diffraction at the MX beamlines of BESSY II can be used to decipher the 3D structure of proteins. To date, more than 5000 structures have been solved at the three MX beamlines. Here, we present a review and an outlook with Manfred Weiss, head of the research group for macromolecular crystallography.
- Humboldt-Fellow at HZB-Institute for Solar Fuels: Alexander R. UhlAlexander R. Uhl, UBC Okanagan School of Engineering in Kelowna, Canada, aims to develop with Roel van de Krol from the HZB Institute for Solar Fuels an efficient and inexpensive photoelectrolyser for producing hydrogen using sunlight. His stay is being funded by the Alexander von Humboldt Foundation.